Skip to main content
OpenTrials
Completed

NCT Number: NCT06169709

An Online Survey for Women With Attention Deficit Hyperactivity Disorder (ADHD)

The goal of this exploratory study following a cross-sectional online survey in women with ADHD is to

1. describe overall experiences regarding ADHD symptoms, diagnosis, treatment, sources of support, and any perceived barriers on those domains; 2. determine which life domains are most affected by ADHD symptoms; 3. calculate the prevalence of reported health conditions within the following domains: circulatory system, endocrine or metabolic system, gastrointestinal system, genitourinary system, musculoskeletal system, nervous system, respiratory system, skin, reproductive system, cancer, psychiatric conditions, COVID-19, sensory sensitivity, menstrual cycle, and sleep; 4. identify topics that women with ADHD would like to see studied in future research.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Parnassia Groep

The Hague, Netherlands

About this study

Rationale: In clinical practice, the investigators see that ADHD affects women differently than men. It has become clear that a better understanding of ADHD in girls and women is needed to improve their longer-term wellbeing and functional and clinical outcomes.

Objective: The primary endpoint is to describe the overall experience of women with ADHD regarding ADHD symptoms, diagnosis, treatment, and any perceived barriers relating to these domains. The investigators also want to determine the effects of ADHD symptoms on day-to-day life across various life domains. Moreover, the investigators want to determine the prevalence of reported health conditions.

Study design: This is an exploratory study following a cross-sectional online survey.

Study population: Women (aged >18 years) with ADHD.

Intervention (if applicable): Not applicable.

Main study parameters/endpoints: In women with ADHD, the investigators want to 1) describe overall experiences regarding ADHD symptoms, diagnosis, treatment, sources of support, and any perceived barriers on those domains; 2) determine which life domains are most affected by ADHD symptoms; 3) calculate the prevalence of reported health conditions within the following domains: circulatory system, endocrine or metabolic system, gastrointestinal system, genitourinary system, musculoskeletal system, nervous system, respiratory system, skin, reproductive system, cancer, psychiatric conditions, COVID-19, sensory sensitivity, menstrual cycle, and sleep; 4) identify topics that women with ADHD would like to see studied in future research.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: This survey is the first to study experiences and health of women with ADHD internationally, and results will provide insights and leads for all involved with diagnosis and treatment of these women. Risks of participation are considered low. Participants might consider certain questions triggering, but are always free to skip questions and stop the survey.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Identify as a woman
  • Aged 18 or above
  • Have ADHD (both diagnosed by a health professional and self-diagnosed)

Exclusion criteria

  • People who are not able to read, understand, or sign the information letter or informed consent form are excluded from participation.

Treatment and study plan

Primary outcomes

  1. To describe the overall experiences, thoughts, and perspectives of women with ADHD, including domains of ADHD diagnosis and symptoms, ADHD and other health conditions, menstrual cycle, conflict tactics and romantic relationships, and sleep.

    Time frame: 50 minutes

    A self-developed questionnaire. The sections on demographic information, ADHD diagnosis, ADHD diagnosis & symptoms and menstrual cycles are constructed for the purpose of this survey. Moreover, the questionnaire contains sections from the Ultrashort screener for adult ADHD, the Holland Sleep Disorder Questionnaire and the Conflict Tactics scale 2.

Secondary outcomes

  1. To identify topics for further research and ways of improving healthcare (e.g. the diagnostic process or effective treatment) for women with ADHD

    Time frame: 50 minutes

    Questions are included in the questionnaire described for outcome 1.

Sponsors and collaborators

Lead sponsor

Parnassia Groep

Other

Registry information

Official study title

Diagnosis and Experiences From Women With ADHD; an International Survey

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Dec 13, 2023
Registry last updated
Jul 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.